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Summary
Female reproductive capacity declines dramatically in the fourth
decade of life as a result of an age-related decrease in oocyte
quality and quantity. The primary causes of reproductive aging
and the molecular factors responsible for decreased oocyte
quality remain elusive. Here, we show that aging of the female
germ line is accompanied by mitochondrial dysfunction associ-
ated with decreased oxidative phosphorylation and reduced
Adenosine tri-phosphate (ATP) level. Diminished expression of
the enzymes responsible for CoQ production, Pdss2 and Coq6,
was observed in oocytes of older females in both mouse and
human. The age-related decline in oocyte quality and quantity
could be reversed by the administration of CoQ10. Oocyte-
specific disruption of Pdss2 recapitulated many of the mitochon-
drial and reproductive phenotypes observed in the old females
including reduced ATP production and increased meiotic spindle
abnormalities, resulting in infertility. Ovarian reserve in the
oocyte-specific Pdss2-deficient animals was diminished, leading
to premature ovarian failure which could be prevented by
maternal dietary administration of CoQ10. We conclude that
impaired mitochondrial performance created by suboptimal
CoQ10 availability can drive age-associated oocyte deficits caus-
ing infertility.
Key words: Mitochondria; mouse models; molecular biology
of aging; individual; fecundity; anti-aging.
Introduction
Female fertility is one of the first physiological functions adversely
affected by aging. Female fecundity starts declining at age 32 and
decreases more rapidly after age 37 (O’Connor et al., 1998). This
decrease in the probability of conception occurs in spite of continuing
ovulatory cycles (te Velde & Pearson, 2002). Although neuroendocrine
and uterine factors contribute to the age-related decline of successful
pregnancy, the consistent live-birth rate of pregnancies from oocyte
donation in aging women suggests that the decline in oocyte quality is
the major contributing factor responsible for infertility with aging.
Maternal aging is known to trigger a series of molecular alterations that
drive the defects in chromatid separation (Chiang et al., 2011) and
chromosome decondensation, as well as spindle detachment causing
chromosomal misalignment (Battaglia et al., 1996; Liu & Keefe, 2002).
However, only a few targets responsible for these changes have been
identified, and no treatment thus far has been successful in improving
the chances of a live birth in women of advanced maternal age.
Decline in female reproductive capacity with aging is accompanied by
depletion of ovarian reserve. In human, progressive loss of ovarian
follicles is nonlinear and becomes accelerated with age, especially after
38 years of age (Faddy, 2000). Molecular pathways behind increased
loss of germ cells in aged ovaries are poorly understood. Increased DNA
damage due to less active DNA repair machinery is one possible trigger
for oocyte loss (Titus et al., 2013). The complex process of oocyte
maturation prior to ovulation involves nuclear, cytoplasmic, and epige-
netic changes culminating with the formation of the meiotic spindle. All
of these processes require energy, which is provided by mitochondria
mostly via oxidative phosphorylation – OXPHOS (Dumollard et al., 2007),
as the alternative energetic process of glycolysis in the oocyte is limited
due to low expression of phosphofructokinase (Leese & Barton, 1984).
The bioenergetic state of the oocyte influences its developmental
competence with correlations between implantation potential, ATP
content (Van Blerkom et al., 1995), and mitochondrial membrane
potential (Wilding et al., 2001). Furthermore, interference with OXPHOS
or with mitochondrial function leads to arrest of oocyte maturation,
chromosomal misalignment, and compromised embryo development
(Takeuchi et al., 2005; Thouas et al., 2006; Wyman et al., 2008).
ATP production via OXPHOS involves the action of the electron
transfer chain consisting of five complexes located on the inner
mitochondrial membrane. Complexes I and II oxidize products of the
tricarboxylic acid (TCA cycle) and transfer the electrons to ubiquinone,
also known as coenzyme Q (CoQ). The electrons are transferred to
complexes III and IV, creating a proton gradient which culminates in the
generation of ATP by complex V. CoQ is pleiomorphic having critical
antioxidant properties, controlling cellular redox, altering various signal-
ing pathways, and influencing transcriptional activity of cells and is
required for the activity of succinate dehydrogenase (Crane, 2001;
Quinzii et al., 2010).
Several observational studies demonstrated a tissue-specific decline in
CoQ levels with age (Kalen et al., 1989; Miles et al., 2004). De novo
CoQ production involves a complex but poorly understood biochemical
pathway, depending on the activity of at least 10 different enzymes. The
benzoquinone ring of CoQ is synthesized from the amino acid tyrosine or
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phenylalanine, and the tail is produced from acetyl-CoA by the
mevalonate pathway through the action of tetrameric decaprenyl
diphosphate synthase, encoded by the Pdss1 and Pdss2 genes. Upon
condensation of the ring with the polyprenyl tail by the COQ2 enzyme,
the ring structure is modified by decarboxylation, hydroxylation, and
methylation, mediated by enzymes encoded by Coq 3, 6, and 7. CoQ
proteins form a large mitochondrial complex (Tran & Clarke, 2007), and
the presence of all protein components is required to maintain its
stability (Wang & Hekimi, 2013). The aim of this study was to determine
whether impaired oocyte mitochondrial function could be improved by
supplementation with mitochondrial energy-production stimulants and
to determine whether oocyte-specific inhibition of CoQ synthesis could
recapitulate the reproductive abnormalities seen with aging.
Results
As maternal aging is accompanied by reduction of mitochondrial
function in oocytes (Kujjo et al., 2013), we treated aged dams with
known stimulators of mitochondrial bioenergetics, CoQ10, alpha lipoic
acid, and resveratrol. CoQ10 significantly improved ovulation rates in
this model (Fig. S1A). Thus, we focused our further experiments to
determine whether CoQ10 can ameliorate other aging-mediated phe-
notypes in the female germ line. After confirming that ovarian response
was improved in a larger cohort of females treated with CoQ10 (Fig. 1),
we evaluated whether ovarian reserve and breeding performance with
aging can also be improved. While substantial ovarian reserve was lost
during a 3-month treatment (from 9 to 12 months Fig. S1B), ovarian
histomorphometry confirmed increased numbers of primordial, prean-
tral, and antral follicles in the CoQ10-treated group compared to the
aged-matched vehicle-treated cohort (Fig. 1A). As preservation of
ovarian reserve does not necessarily mean production of better quality
oocytes, we subjected females to a breeding trial. The reduced litter size
observed in the old vehicle-treated dams was normalized with CoQ10
(Fig. 1C). Thus, CoQ10 supplementation not only preserved the ovarian
follicle pool, but also facilitated ovulation of gametes able to support
normal development.
Mitochondrial dysfunction has been implicated in oocyte aging (Bentov
et al., 2011). As CoQ is awell-knowncomponent of the electron transport
chain, we next evaluated whether CoQ10 treatment could improve
mitochondrial performance in oocytes. We determined that the pool of
respiring mitochondria was decreased in aged oocytes and increased by
CoQ10 treatment to the level similar to that of young controls (Fig. 2A).
Decreased mitochondrial activity in aged oocytes was reflected by lesser
reduction of FAD++ to FADH2 as the oxidized (fluorescent) FAD++ to
MitoTracker (active mitochondrial pool) ratio was increased with age and
this was normalized by CoQ10 (Fig. 2A). On the contrary, mitochondrial
membrane potential was elevated with aging (Fig. 2A) and restored to
levels seen in the younganimals after CoQ10 exposure.During completion
of meiosis I, mitochondrial output and ATP demands are dramatically
increased (Dalton et al., 2014). This can be monitored by increase in
mitochondrially derived reactive oxygen species (ROS – Mitosox). ROS
levels decreased with aging and were restored in the oocytes of CoQ10-
treated dams (Fig. 2A). Both ATP output and oxygen consumption were
decreased with aging and significantly increased upon CoQ10 adminis-
tration (Fig. 2B). Consistent with these outcomes, metabolites of the TCA
cycle, including citrate, malate, and to a lesser extend fumarate were
reducedwith aging and increasedwithCoQ10 treatment to the levels seen
in the young controls (Figs 2B and S2). Outcomes of these studies indicate
the inhibition of the TCA cycle activity is a major reason for poor
mitochondrial function in aged oocytes.
Using previously published outcomes of microarrays studies on aged
murine oocytes (Hamatani et al., 2004; Pan et al., 2008), we established
that expression of genes involved in mitochondrial metabolism was
reduced by aging. Expression of Sdha and Nduf3, the mitochondrial ROS
scavenger Sod1 as well as the ATP-dependent chromatin regulator
Smarca2 (Fig. 2C) were all significantly decreased in the oocytes of the
(A)
(B) (C)
Fig. 1 Impact of CoQ10 treatment on ovarian reserve and breeding performance in an aged mouse model. (A) Ovarian reserve was significantly higher in old vehicle
mice treated with CoQ10 for a period of 15 weeks (n = 9/age and treatment) evidenced by significantly higher number of resting primordial and growing secondary follicles.
Values represent average follicle numbers  SEM. Images of stimulated ovaries from each group are shown on the right – magnification 509. (B) Number of ovulated
oocytes collected after hormonal stimulation of young (n = 20), old vehicle-treated (n = 16), and old CoQ10-treated dams (n = 16). Values represent average number of
oocytes per female  SEM. (C) Litter size in young (n = 39), old vehicle-treated (n = 15), and old CoQ10-treated mice (n = 11). The number of live pups born to dams in
the 13th month of age was decreased, but normalized after CoQ10 supplementation. Each female produced only one litter during breeding trial. Scatter plot data are
shown as mean per female  SEM.
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aged animals and increased in the CoQ10-treated aged group. In
contrast, CoQ10 supplementation had no significant impact on expres-
sion of genes involved in transcription or chromatin organization
(Cggbp1, Arf1, Ezh2, Bmi1, Rbbp4, Kpna2) (Fig. S2). Thus, we conclude
that maternal treatment with CoQ10 boosts mitochondrial function in
aged oocytes, restores activity of TCA cycle, and normalizes energy
production.
Various mouse models have linked bioenergetic status of oocytes to
abnormal meiotic outcomes, particularly defects in spindle positioning
and chromosome scattering (Wang et al., 2009; Luzzo et al., 2012). We
thus assessed the metaphase II spindle and chromosomal alignment of
ovulated oocytes. As previously reported, aging was accompanied by the
production of oocytes with higher rates of spindle defects and
chromosomal misalignment. CoQ10 treatment in the old mice restored
normal spindle appearance and prevented chromosomal scattering to a
degree indistinguishable from young dams (Fig. 3A). In addition,
transcript levels of genes involved in meiotic progression such as
Tuba1a, Nek2, and Hook1 were all significantly increased after CoQ10
treatment in the old animals (Fig. 3B), while no change was observed for
Ccna2 (Fig. S2). Most importantly, the litter sizes of live-born pups in the
CoQ10-treated older mice were similar to the litter sizes seen in the
young animals (Fig. 1C).
The source of CoQ10 in most tissues is believed to originate from
endogenous production because the bioavailability of CoQ10 from the
diet is very low. In rodents, the major CoQ variant is CoQ9 with a
variable content of CoQ10 that differs among tissues. Similar to liver, the
ovary appears to efficiently uptake CoQ10 from external sources without
dramatic impact on endogenous CoQ9 levels. (Table S1).
We next proceeded to determine whether aging oocytes express
altered levels of enzymes involved in CoQ biosynthesis. Quantitative
RT–PCR of growing (GV) stage oocytes revealed a significant decrease in
Coq6 and Coq9 expressions (Fig. 4A) but no change in the Pdss1/2
transcript levels. To establish whether human oocytes demonstrate the
same molecular changes as the mouse, we assessed expression of these
targets in GV oocytes obtained from patients undergoing IVF treatment.
Similar to the mouse, a significant decline in CoQ6 expression was
observed in the oocytes of older patients (Fig. 4B). Western blot analysis
of ovaries isolated from young and old dams revealed reduction in both
PDSS2 and CoQ6 proteins (Fig. 4C). Immunolocalization on ovarian
sections confirmed expression of PDSS2 and CoQ6 in oocytes of growing
(A) (B)
(C)
Fig. 2 Improvement in mitochondrial function in oocytes of old vehicle mice after CoQ10 supplementation. (A) Oocytes from young, old vehicle and old CoQ10 mice were
stained with MitoTracker Red, JC-1, and Mitosox or examined for green autofluorescence (FAD). The respiring mitochondrial pool (MitoTracker Red) was reduced in oocytes
from old vehicle mice compared to young or old CoQ10, which were not different from each other. The ratio of oxidized FAD (FAD++)/MitoTracker Red increased in old
oocytes. The mitochondrial membrane potential (MMP) increased in old oocytes, while ROS production (Mitosox) decreased. These aging effects were normalized by CoQ10
treatment. Values represent random fluorescence units (RFUs) per oocyte  SEM. For all experiments, individual oocytes were used and groups contained n = 15–25
oocytes/age/treatment. (B) ATP (nM) and TCA cycle metabolites (millimole of substrate per kilogram wet weight per oocyte) were evaluated in individual oocytes from
young (n = 7–15), old vehicle (n = 8–14), and old CoQ10 (n = 11–17). Oxygen consumption is expressed as a ratio of fluorescent signals obtained by a scan 1 min apart and
reflects oxidative decay of the probe per oocyte. Data shown are mean  SEM. (C) Expression levels of genes involved in mitochondrial function (Ndufs3, Sdha, and Sod1)
and chromatin organization (Smarca2) in ovulated oocytes were reduced with aging and improved after treatment with CoQ10 (mean  SEM). Each sample contained a
pool of 3 oocytes (n = 4 young, n = 6 old vehicle and n = 5 old CoQ10 pools), and data are shown as the ratio of reference (actin)/target (studied) transcript.
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follicles (from the secondary follicle stage onwards), as well as lower,
albeit detectable, expression in the stroma, theca, cumulus, and
luteinized granulosa cells (Fig. S4). As declining levels of PDSS2 and
CoQ6 in ovarian lysates could reflect altered tissue composition (e.g.,
decreased follicle pool), we performed immunocytochemistry on GV
stage oocytes isolated from young and old females. Both PDSS2 and
(A) (B)
Fig. 3 CoQ10 rescues spindle defects in aging oocytes. (A) Percent of chromosomal or spindle misalignment in ovulated oocytes from young (n = 60), old (n = 73), and old
CoQ10 (n = 51) mice. Oocytes were stained with antitubulin antibody (green) and DAPI (red). Representative images of normal spindle (barrel shaped) and chromosome
alignment (toothbrush appearance) were considered normal. Arrows demonstrate detachment of chromosomes from spindle or misshaped spindle organization. Letters (a vs. b
and a* vs. b*) are significantly different from each other (P < 0.05). (B) Expression of genes implicated in spindle formation/attachment and meiotic execution (Tuba1a,
Hook1, Nek2, and Smarca2) in oocytes was reduced with aging and improved after treatment with CoQ10. Each sample contained a pool of 3 oocytes, and each age
category was represented by n = 4 young, n = 6 old, and n = 5 old CoQ10 pools, and data are shown as the mean ratio of reference (actin)/target  SEM.
(A) (B)
(C)
Fig. 4 Reduced expression of CoQ10 biosynthesis genes in oocytes with aging. (A) Fold change in mRNA level of pooled GVs (3 per sample; n = 6 young, n = 6 old) were
normalized to young age. Transcripts encoding enzymes Pdss1 and Pdss2 did not change with aging, but the expression of the enzymes involved in modifying the
hydroxybenzoate ring (Coq6 and Coq9) significantly decreased. (B) Fold change in mRNA level of CoQ10 synthesis genes in single human GV oocyte per patient (n = 8
patients <32 years old, n = 8 patients >39 years old females). Data are shown as mean  SEM and are normalized to actin. (C) Immunocytochemistry of GV oocytes
exposed to anti-PDSS2 and anti-COQ6 antibodies from young (n = 9) and old vehicle mice (n = 5). Values represent mean fluorescence units  SEM. Western Blot of whole
ovarian lysates from young (3 months old) and aged mice (12 months old) blotted with anti-PDSS2, anti-COQ6, and anti-actin antibodies.
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CoQ6 were significantly reduced with age (Fig. 4C) in oocytes, although
we did not observe significant reduction in CoQ9/10 level in total ovarian
lysates in aged animals (Table S1). As oocytes only represent a very small
fraction of the total ovarian tissue content, changes that occur in these
cells would be untraceable.
Previous work has established that disruption of Pdss2 and prevention
of CoQ synthesis are embryonic lethal. However, it is currently unknown
whether the function of this enzyme is required for oogenesis. We used
conditional disruption of Pdss2 in oocytes to investigate whether
interruption of CoQ10 synthesis will affect ovarian reserve. The ZP3-
Cre3Mrt line has a high efficiency of excision (~98%),with activity restricted
to oocytes initiated at the primordial follicle stage (Fig. S3A). PDSS2 levels
were reduced in growing GV oocytes of Pdss2 fl/fl Cre+mice (Fig. S3B), and
immunoreactivity was virtually absent in fully grown oocytes (Fig. S3C).
Although the Pdss2 fl/fl Cre females had an averageof 6 pups per litter, the
Pdss2 fl/fl Cre+ females (n = 4) did not produce any viable offspring during
an entire 3-month breeding trial when crossed with males of proven
fertility (Fig. S3D). By 4 months of age, Pdss2 fl/fl Cre+ female ovaries
contained no healthy follicles and were accompanied by a hypotrophic
uterus, a condition resembling premature ovarian failure. The ovulation
rate at 4 weeks of age, shortly after the onset of puberty, revealed a
decreased number of ovulated oocytes, and the ovarian reserve of the
Pdss2 fl/fl Cre+ mice was already severely compromised, evidenced by the
loss of 50% of follicles (Fig. 5A,B).
We next investigated whether oocytes ovulated by young Pdss2 fl/fl Cre+
females exhibitedmitochondrial phenotypes similar to those found in the old
females. The respiring mitochondrial pool (e.g., MitoTracker Red), mito-
chondrial ROS, and ATP were all significantly decreased (Fig. 5C,D). In
addition, a higher proportion of oocytes from Pdss2 fl/fl Cre+ females
contained misalignment of chromosomes, suggesting that disruption of
the CoQ10 biosynthetic pathway could contribute to abnormal meiotic
outcomes observed with increased maternal age (Fig. 5E). As we
have observed reduced CoQ6 levels in aged oocytes, we examined whether
this outcome could be a response to PDSS2 deficiency. Indeed, Pdss2-
deficientGVoocytesalsoexpresseda reduced level ofCoQ6protein (Fig. 5F).
To determine whether CoQ10 is the factor responsible for poor
ovarian reserve caused by Pdss2 deficiency, we exposed mothers during
pregnancy/lactation to CoQ10 with subsequent dietary supplementation
of pups with CoQ10 through suckling. At 2 months of age, control
Pdss2 fl/fl Cre+ mice displayed severely reduced ovulation rates accompa-
nied by reduction in ovarian reserve. This phenotype in the pups was
partially corrected by lactational exposure to CoQ10 (Fig. 5B). In
addition, mitochondrial membrane potential, ATP production, and
superoxide levels were improved in the CoQ10-supplemented animals,
without a change in the respiring mitochondrial pool (Fig. 5B,C). We
also observed an improvement in spindle and chromosomal alignment
(Fig. 5D). Interestingly, exposure of young Pdss2 fl/fl females to CoQ10
did not alter ovarian reserve, breeding, ovulation rates, or mitochondrial
function (Fig. S4). These results indicate that diminished synthesis of CoQ
created by oocyte-specific Pdss2 disruption is sufficient to alter ovarian
function, suggesting that deficiency of CoQ may contribute to the
accelerated oocyte loss and poor pregnancy outcomes seen with aging.
Discussion
In this study, we demonstrate that CoQ10 supplementation in an aged
animal model delayed depletion of ovarian reserve, restored oocyte
mitochondrial gene expression, and improved mitochondrial activity. As
a result, more oocytes were ovulated in aged mice, developmental
potential of the oocytes was improved, and more pups were born. The
conditional disruption of the Pdss2 gene resulting in CoQ deficiency in
oocytes recapitulated many of the phenotypic changes characteristic of
oocyte mitochondrial dysfunction associated with reproductive aging.
These changes could be reversed by feeding the animals CoQ10. CoQ10
supplementation had no impact on ovarian reserve or oocyte quality of
young females, suggesting no beneficial reproductive effect of CoQ10 in
animals in which mitochondrial function is intact.
The reproductive aging process in mammals includes progressive
reduction in ovarian follicular reserve with decreased oocyte quality.
Increased loss of ovarian follicles with aging had been confirmed both in
rodent and in human ovaries (Faddy et al., 1983; Faddy, 2000). We
detected a significantly higher number of primordial follicles after
12 weeks of treatment with CoQ10. When we performed follicle
counts, we did not see any dying primordial oocytes in aged ovaries,
based on morphology and chromatin condensation. Therefore, the most
likely explanation for the observed increase in the number of follicles is
due to decreased atresia. The second alternative possibility to increase
primordial follicle reserve is a decrease in recruitment toward growth.
However, as we see slightly more primary oocytes in the CoQ10
treatment group, this is an unlikely explanation.
Previously published microarray studies comparing old and young
oocytes revealed altered expression of genes responsible for mitochon-
drial function, oxidative stress responses, chromosome alignment, and
ubiquitination (Hamatani et al., 2004; Pan et al., 2008). Ultrastructural
examination of cellular organelles in aging oocytes confirmed the defects
in mitochondrial architecture (Kujjo et al., 2013). Based on the outcomes
of our study, it is clear that defects in mitochondrial performance occur
concomitantly with the decline in breeding performance, and we
attribute these changes to insufficient production of CoQ by oocytes.
DNA damage is another contributing factor to oocyte aging (Titus et al.,
2013), and it remains to be determined whether CoQ9/10 deficiency may
accelerate DNA damage. However, it is clear that disruption of Pdss2 in
oocytes is sufficient to trigger mitochondrial defects reminiscent of aging.
CoQ10 is essential for mitochondrial activity as point mutations in
enzymes responsible for CoQ10 synthesis are characterized by pheno-
types involving high energy-consuming tissues such as the central
nervous system, skeletal muscle, and the kidney (Lopez et al., 2006;
Peng et al., 2008; Heeringa et al., 2011), and these symptoms can be
partially alleviated by the administration of CoQ10. Unlike most rodent
tissues in which CoQ9 is the predominant form of ubiquinone, the
ovaries produce relatively high levels of CoQ10 and are able to efficiently
uptake CoQ10 from external sources. We observed transcriptional
decrease in CoQ6 in aged oocytes and concomitant decrease in PDSS2
protein level. Reciprocal relationship exists between these two enzymes,
as disruption of Pdss2 triggered decrease of CoQ6 protein. Similar
changes were previously described for CoQ9 and CoQ7 (Garcia-Corzo
et al., 2013). It is possible that disruption of key elements in the CoQ
pathway could result in altered stability of whole CoQ enzyme complex
(Wang & Hekimi, 2013).
In human, CoQ10 concentrations decrease after 30 years of age in
some tissues (Morre et al., 2003; Miles et al., 2004), and perhaps this
contributes to the aging process. The timing of the age-related decline in
CoQ10 availability seems to coincide with the decline in fertility and the
increase in embryo aneuploidies. Indeed, correlation between low
plasma CoQ10 levels and spontaneous abortions were previously
reported (Noia et al., 1996). In addition, levels of CoQ10 in the follicular
fluid correlate with oocyte maturation and embryo grade during in vitro
fertilization (Turi et al., 2012). Our results suggest that the oocyte is the
beneficial target of CoQ10 supplementation. However, it is also possible
that granulosa/cumulus cells and/or the uterine environment may also
Oocyte aging and CoQ10 deficiency, A. Ben-Meir et al. 891
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benefit and thus contribute to the increased reproductive capacity of
CoQ10-treated females.
Due to limitations of technology, we have been unable to measure
CoQ9/10 levels in oocytes. However, we demonstrate that the expres-
sion of multiple CoQ synthesis enzymes decreases with aging in human
and murine oocytes, and cell-specific disruption of the CoQ synthesis
pathway in young animals impacts negatively on oocyte quality. Thus,
the oocytes, similar to podocytes in the kidney (Peng et al., 2008),
dopaminergic neurons in the substantia nigra (Ziegler et al., 2012), and
glial cells/neuroblasts in cerebellum (Lu et al., 2012), appear to be
exquisitely sensitive to decreased CoQ levels. As CoQ10 administration
improved breeding outcomes, slowed down follicle loss, and improved
oocyte mitochondrial energetics in the aged animal model, it is tempting
to propose that dietary CoQ10 supplementation could have beneficial
reproductive effects in women seeking to conceive at a later age. While
our results in an animal model appear promising, there are tremendous
differences between aging mice and women, not the least of which is
the order of magnitude difference in life expectancy. In relative terms,
the use of CoQ10 for 12–16 weeks in a mouse is equivalent to about a
decade in human. In addition, it is unknown whether a mitochondrial
nutrient such as CoQ10 alone could reverse the impact of decades of




Fig. 5 Decreased ovarian reserve and oocyte quality in Pdss2 fl/fl Cre+ mice is rescued by CoQ10 supplementation. (A) The follicular count of ovaries (mean  SEM) from
4-week-old vehicle mice revealed decreased ovarian reserve in Pdss2 fl/fl Cre+ (n = 8) compared to Pdss2 fl/fl Cre mice (n = 5). Follicle loss is reflected also by the reduced
ovulation rate (n = 8 Pdss2 fl/fl Cre+, n = 16 Pdss2 fl/fl Cre). (B) Treatment with CoQ10 from birth till 7 weeks of age prevented loss of ovarian reserve (mean  SEM) and
improved the ovulation rate triggered by Pdss2 deficiency. (C) Oocytes from Pdss2 fl/fl Cre+ exhibit mitochondrial dysfunction with decreased respiring mitochondrial pool,
reduced mitochondrial membrane potential (MMP), and decreased ROS production. Similar to aging, MMP and mitochondrial ROS levels were significantly improved
under CoQ10 supplementation. (D) ATP output per oocyte improved by CoQ10 administration in Pdss2 fl/fl Cre+ females. All data shown are mean  SEM obtained from
20–40 oocytes. (E) Chromosomal misalignment was significantly more frequent in oocytes from Pdss2 fl/fl Cre+ (n = 62) compared to Pdss2 fl/fl Cre (n = 118), and this was
corrected by CoQ10 administration (n = 56). (F) Anti-COQ6 protein level in growing GV oocytes. Pdss2 fl/fl Cre+ oocytes present with significantly reduced levels of CoQ6
protein (n = 31 Pdss2 fl/fl Cre, n = 44 Pdss2 fl/fl Cre+).
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studies on dosing, length of treatment, and clinical outcomes safety are
necessary before the use of CoQ10 in a clinical setting.
Experimental procedures
Animals and treatment
Institute of Cancer Research (ICR) female mice were obtained from
Harlan Laboratories Inc. (Mississauga, Canada). All mouse experiments
were performed in accordance with the Canadian Council on Animal
Care (CCAC) guidelines for Use of Animals in Research and Laboratory
Animal Care under protocols approved by animal care committees at
Mount Sinai Hospital or the Toronto Centre for Phenogenomics. All mice
were housed with free access to food and water, and kept on a 12-h:12-h
light/dark cycle. For aging experiments, only proven (retired) breeders
were used, while young controls were virgin females (7–8 weeks old).
For conditional disruption of Pdss2 in oocytes, mice carrying the loxP
allele of Pdss2tm1.1Dalg were crossed with transgenic ZP3-Cre3Mrt animals
(Lewandoski et al., 1997), and genotyping was performed as previously
described. Efficiency of excision in the ZP3-Cre line was tested by the
ZAPCAG-Bgeo/ALPP reporter.
a-lipoic acid (ALA), resveratrol (Sigma-Aldrich, Oakville, Ontario,
Canada), and CoQ10 (Sigma-Aldrich or Advanced Orthomolecular
Research Inc., Calgary, Alberta, Canada) were dissolved in sesame oil.
Nine-month-old mice were injected subcutaneously with doses of ALA
(33 mg kg1), resveratrol (10 mg kg1), CoQ10 (22 mg kg1), or pla-
cebo (sesame oil) three times a week for a period of at least 12 weeks as
shorter treatment did not show beneficial effects in preliminary breeding
trials. Treatment for 12–13 weeks was used for the analysis of various
outcomes in ovulated oocytes. For rescue experiments in the Pdss2model,
mothers during pregnancy and their offspring after weaning received
CoQ10 (LiQsorb, Tishcon, Westbuty, NY, USA) in drinking water
(0.4 mg mL1) (Saiki et al., 2008).
For breeding performance, dams were set with young male studs of
proven fertility and checked daily for signs of pregnancy and delivery.
Dams were pretreated for 12 weeks and set to breed while still being
treated for one more month period (e.g., final treatment up to 16th
week). Treatment (injections) was stopped when female was pregnant
(as determined by gain of weight ~ day 10.5 postmating). All together
aged females were maintained with males for 4 weeks and 3 more
weeks afterward, while young Pdss2 females were monitored for at least
4 months. Twenty-one aged ICR females were used, although only 15
produced a single litter during this period in the control group. Twelve
females were used for CoQ10 treatment, from which 11 produced a
single litter during the breeding trial.
Ovulation induction, oocyte collection, and assessment of
ovarian reserve
Mice were superovulated with pregnant mare serum gonadotropin
(ProSpec, Rehovot, Israel) and 48 h later with human chorionic gona-
dotropin (hCG) (Sigma-Aldrich) by intraperitoneal injection. For young
females, 5 IU of both gonadotropins was administered, while old
females received 10 IU. Mice were sacrificed by cervical dislocation and
oviducts were removed. The oocytes were retrieved in modified human
tubal fluid (LifeGlobal, Guilford, CT, USA) supplemented with 0.1% BSA
(Sigma-Aldrich) and denuded of cumulus cells using hyaluronidase
(Sigma-Aldrich). Murine germinal vesicle (GV) stage oocytes were
collected 48 h after PMSG priming. Human immature oocytes (GV)
not used for insemination were obtained from women aged 27 to
45 years who were undergoing IVF treatment. The study was approved
by Mount Sinai Hospital (MSH REB Number: 05-0044-E), consent was
obtained from all subjects, and experiments conformed to the principles
of Declaration of Helsinki.
Murine ovaries were fixed in Dietrich’s fixative, embedded, serially
sectioned (fully), and stained, and the number of healthy follicles at
various stages of development was determined by systematic counts on
every tenth section, summarized, and multiplied by a factor of 10. For
excision efficiency, ovaries of ZAPZP3-Cre+ females were collected at
2 months of age, and frozen sections were stained for alkaline
phosphatase activity as previously described (Lobe et al., 1999). The
number of excised oocytes (e.g., blue) was determined by counting 5
random ovarian sections from three females.
Metabolic Assays, Mitochondrial labeling, and spindle
scoring
Microanalytical metabolic assays for citrate, malate, and fumarate levels
were performed as previously described (Chi et al., 2002), and for the ATP
assay, Cell Titer GLO (Promega Madison, WI, USA) was used using ATP as
standard. Ovulated oocytes were stained with MitoTracker Red, ROS –
Mitosox (Invitrogen, USA), DePsifer (Trevigen, Gaithersburg, MD, USA),
and autofluorescence for FAD (FITC) were performed as previously
described (Fernandes et al., 2012). For oxygen consumption (MitoXpress
Intra; Luxcel, Cork, Ireland), zona pellucida was removed with acid
Tyrode’s solution, and oocytes were cultured for minimum of 5 h in the
presence of probe at concentration recommended by amanufacturer and
subsequently imaged on a spinning disk confocal microscope using
appropriate filters. Ten optical sections from each sample were taken
1 min apart from each oocyte and were analyzed by Volocity Image
Analysis Software, PerkinElmer Inc., Waltham, MA, USA. Final data are
shown as ratio of these values. ATP and oxygen consumption assays were
validatedby treatment of oocyteswith8 lMantimycin for 30 min (Fig. S5).
Oocytes were scored for appearance of the spindle structure and
arrangement of the chromosomes. Normal oocyte contained a barrel-
shaped spindle with condensed chromosomes positioned centrally on
the equator of the spindle. Abnormal spindle morphology included a
reduction in the number of microtubules or the size of the spindle and
detachment of the spindle from the chromosomes. Dispersion or
misalignment of chromosomes from chromosomal plate was also
defined as abnormal.
Immunostaining
Ovarian sections fixed in 10% neutral buffered formalin were embedded
in paraffin, sectioned, and rehydrated. Antigen retrieval with citrate
buffer was used prior to exposure to antibody PDSS2 (1:40) followed by
ABC Vectastain Kit (Dako, Glostrup, Denmark). Sections from Pdssfl/fl ZP3-Cre+
females were used as a negative control. Isolated oocytes at the GV
stage were fixed in PHEM fixative, and indirect immunocytochemistry of
the oocytes was performed as previously described (Fernandes et al.,
2012). Primary antibodies included mouse antitubulin (1:500; Invitrogen)
and rabbit anti-CoQ6 or PDSS2 (1:100; 1:200, respectively; Proteintech
Group Inc, Chicago, IL, USA), followed by incubation with donkey anti-
mouse Alexa 488 or donkey anti-rabbit Alexa 594 (Invitrogen). DNA was
counterstained with 40,6-diamidino-2-phenylindole (DAPI) and imaged
on confocal microscope. Values obtained from samples without primary
antibody were subtracted from the experimental signals, and the data
were shown as the sum of intensity expressed as random fluorescence
units (RFUs).
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Quantitative RT–PCR
Following oocyte retrieval, three oocytes were transferred into guanidinium
isothiocyanate (GITC) solution, and cDNA for real-time PCR analysis was
preparedasdescribed (Perumalsamyet al., 2010). The sequences for forward
and reverse primers are listed in Table S2. All gene expression experiments
utilized the SYBR green PCR mix using LiteCycler (Roche, Mississauga, ON,
Canada). qRT–PCR conditionswere as follows: 95 °C for 10 min and then40
cycles of 95 °C for 30 s, 60 °C for 30 s, and 72 °C for 30 s. Comparisons of
expression levelswere determinedby deltaCTmethodnormalized tob-actin.
Western blot
Ovarian protein lysateswere prepared in 1%SDS-RIPA buffer containing a
complete protease inhibitor cocktail (Roche) and protein concentrations
determined using the BCA protein assay. Protein samples were resolved
through 12% acrylamide gels and transferred to PVDF membranes. After
blocking, the blots were probed with rabbit anti-CoQ6 or anti-PDSS2
(1:400 and 1:600, respectively; Proteintech Group Inc) followed by
hybridization with goat anti-actin (Santa Cruz Biotechnology, Dallas,
Texas,USA)asa loadingcontrol.Theblotswerethenwashedandincubated
with appropriate HRP-conjugated secondary antibodies and ECL Plus.
Ubiquinone extraction and measurement
For determination of ovarian ubiquinone (UQ) concentrations, whole
ovaries and livers were homogenized in 0.5 mL of homogenization buffer
(0.25 M sucrose, 10 mMHepes buffer pH 7.4, 1 mM EDTA)with ten passes
of the Teflon pestle homogenizer (Wheaton Overhead Stirrer, Wheaton
Instruments, Millville, NJ, USA). After the total volume was made up to
500 lL with the homogenization buffer, 5 lL of the homogenates was
used to determine their total protein content using the Bradford Reagent
(Bio-Rad Mississauga, ON, Canada). To extract UQ, whole ovarian
homogenates were mixed with an equal volume of hexane/ethanol for
10 min by vortexing. After centrifugation at 9000 g for 10 min, the
hexane layer was collected and evaporated to dryness using a vacuum
centrifuge (Eppendorf, Mississauga, ON, Canada). The quinone residue
was then dissolved in 100% ethanol and analyzed by HPLC with UV
detection at 275 nm (Beckman System Gold, Beckman Coulter Inc, Brea,
CA,USA). A reverse phaseC18 column (25.0 9 0.46 cm, 5 lm,Hichrom,
Berkshire, UK) was used with an isocratic elution at a flow rate of
1.8 mL min1. The mobile phase was methanol/ethanol (70:30 v/v). The
concentrations of ubiquinones were estimated by comparison of the peak
area with those of standard solutions of known concentration. Finally,
quinone amount was normalized to protein content in the samples.
Statistical analysis
All results are given as mean  SEM. All statistical tests were performed
with SIGMAPLOT 11 (Systat Software Inc., San Jose, CA, USA). Analyses
were performed either with a one-way ANOVA followed by Tukey’s or
Dunn’s post-test, Mann–Whitney rank sum test, with the student’s t-test
or chi-squared analysis, where appropriate. Results were considered
statistically significant if P < 0.05.
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Fig. S1. (A) Ovulation rate of 12 months old mice from control vehicle
(n = 9), CoQ10 (n = 8), ALA (n = 7) and Resveratrol (n = 9) treated females.
The CoQ10-treated group was the only one to show significant increase in
ovulation rate compared to control. (B) Ovarian follicle reserve in ICR retired
breeders at 9 month of age at the start of treatment and after 12 month of
age (data for 12 months is the same as those in Fig. 1).
Fig. S2. (A) Level of gene expression (mRNA) in GV oocytes from young, old
and old-CoQ10 treated mice which did not show significant change with age
and/or with treatment. Values represent ratio of b-actin to target gene levels.
(B) Fumarate levels were not significantly reduced by age, but were
upregulated by CoQ10 treatment.
Fig. S3. Validation of ZP3Cre activity in oocytes. (A) Ovaries from ZAPCAG-
Bgeo/ALPP ZP3-Cre+ mice. Cre activity is restricted to oocytes and is initiated
already at primordial follicle stage (arrows). (B) PDSS2 protein levels were
significantly reduced in growing GV oocytes of 3 weeks old Pdss2 fl/fl Cre+
(n = 14) compared to Pdss2 fl/fl Cre (n = 12), indicating excision efficiency.
(C) Antral follicles with fully grown oocyte present absence of Pdss2 activity in
Pdss2 fl/fl Cre+ mice (arrowheads), while immunoreactivity is still observed in
the cumulus cells surrounding the oocyte (arrows). (D) Breeding performance
of young fl/fl and fl/fl Cre+ mice during 4 months breeding trial.
Fig. S4. Supplementation of with CoQ10 (LiQsorb) has no effect on (A)
breeding (e.g. litter size), (B) ovulation rates, (C) ovarian reserve, (D)
mitochondrial respiration (Mitotracker Red intensity or ROS production) and
E) ovulation of chromosomally abnormal oocytes in young (up to 3–4 month
of age) Pdss2 fl/fl (WT) females and (F) ATP level. However, similar to
administration of subcutaneous CoQ10, LiQsorb did improve oocyte ATP
level in 12 month old treated Pdss2 fl/fl females (G).
Fig. S5. Validation of ATP and Oxygen consumption assay. Ovulated oocytes
were collected and cultured in HTF medium with or without antimycin for
30 min followed by measurement of ATP (nM) (A) or oxygen consumption
based on imaging of MitoXpress Intra (B) expressed as ratio of probe
fluorescence taken in a 1 min interval. Data shown are mean  SEM n = 16
oocytes for ATP experiment and n = 10 for oxygen consumption experiment.
Both assays show significant reduction of signal (P < 0.001) after inhibiting
activity of Complex III.
Table S1. Level of CoQ9 and CoQ10 (ng mg1 of protein) after supple-
mentation in various tissues.
Table S2. List of primers used for gene expression studies.
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